ITGAM and neoplasm: The majority of the tumor-infiltrating S100A4WT-EGFP immune cells were CD11b+ or F4/80+ myeloid cells, whereas lymphocytes, including T cells, B cells and NK cells, were in the minority (figure 1A and online supplemental figure 1A).